Welcome to Maple NEXUS Bio

We support pharmaceutical companies, biotech firms, and research organizations by facilitating access to proven development capabilities through a structured and compliance-aware collaboration model. 

Maple NEXUS Bio operates as a facilitator and integrator within the biologics ecosystem.

We do not perform development activities in-house. Instead, we:

• Identify and connect clients with qualified development and manufacturing partners 
• Align projects with appropriate technical capabilities and platforms 
• Support coordination across multiple stages of development 
• Enable efficient and structured progression from early-stage research to clinical readiness 

This model allows clients to access end-to-end capabilities without being limited to a single provider.

 Through our global partner network, we enable access to capabilities across the biologics development pathway:

• Gene selection and optimization 
• Vector design and engineering 

• Cell transfection and clone selection 
• Stable, high-expression cell line generation 
• Cell banking and stability support 

• Upstream (cell culture) optimization 
• Downstream purification strategies 
• Process scale-up and reproducibility 

• Product quality and comparability assessment 
• Impurity profiling and control strategies 
• Support for critical quality attributes (CQAs) 

• Documentation and data coordination 
• Alignment with CMC requirements 
• Preparation for regulatory submission pathways 

Maple NEXUS Bio supports development programs involving:

• Biosimilar products 
• Monoclonal antibodies (mAbs) 
• Recombinant DNA–derived therapeutics 
• Kinase inhibitor–related development support 
• Anticancer and targeted therapy products

We collaborate with a network of specialized organizations, including:

• Biopharmaceutical and biotechnology companies 
• Contract Development and Manufacturing Organizations (CDMOs) 
• Research and technology providers 

This network enables flexible, scalable, and project-specific development pathways tailored to each client’s needs.

All activities are coordinated through partners operating within established quality and regulatory frameworks. Our approach emphasizes:

• Alignment with Quality by Design (QbD) principles 
• Support for CMC documentation requirements 
• Transparency and traceability across development stages 
• Awareness of global regulatory expectations for biologics 

Unlike single-service providers, Maple NEXUS Bio enables access to a broad ecosystem of specialized capabilities, allowing clients to:

• Select the most suitable partners for each stage 
• Avoid dependency on a single development platform 
• Scale programs efficiently across regions 
• Navigate complex biologics development with flexibility

For biosimilar development, monoclonal antibody programs, or biologics process support, we invite you to connect with our team to explore tailored collaboration pathways.

👉 Contact Us

 Maple NEXUS Inc. operates as a business-to-business facilitation and coordination partner. Development, manufacturing, and analytical activities are performed by qualified third-party organizations in accordance with applicable regulatory requirements.